Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Friedman Industries
FRD
$248M
| $3.21M | ﹤0.01% |
564,900
+43,534
| +8% | +$251K |
|
2077
Magnite
MGNI
$2.83B
| $3.2M | ﹤0.01% |
1,712,300
+836,524
| +96% | +$2.09M |
|
2078
Republic Bancorp
RBCAA
$1.96B
| $3.19M | ﹤0.01% |
84,000
-4,400
| -5% | -$177K |
|
2079
German American Bancorp
GABC
$1.93B
| $3.19M | ﹤0.01% |
90,300
-19,200
| -18% | -$702K |
|
2080
WisdomTree India Earnings Fund ETF
EPI
$2.04B
| $3.18M | ﹤0.01% |
+114,100
| New | +$3.04M |
|
2081
CGI
GIB
$15.4B
| $3.18M | ﹤0.01% |
+58,400
| New | +$3.11M |
|
|
EFC
2082
Ellington Financial
EFC
$1.69B
| $3.17M | ﹤0.01% |
218,564
+28,320
| +15% | +$431K |
|
2083
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
| $3.17M | ﹤0.01% |
+36,212
| New | +$3.17M |
|
2084
Hurco Companies Inc
HURC
$132M
| $3.16M | ﹤0.01% |
74,882
+9,600
| +15% | +$417K |
|
2085
Caterpillar
CAT
$361B
| $3.15M | ﹤0.01% |
20,000
-1,050,600
| -98% | -$146M |
|
|
RVNC
2086
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.14M | ﹤0.01% |
87,956
+8,164
| +10% | +$234K |
|
2087
Genworth Financial
GNW
$3.86B
| $3.14M | ﹤0.01% |
1,008,300
-1,347,800
| -57% | -$4.66M |
|
|
ALTA
2088
DELISTED
Altabancorp
ALTA
| $3.12M | ﹤0.01% |
103,100
-3,314
| -3% | -$104K |
|
|
ULQ
2089
DELISTED
CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF
ULQ
| $3.12M | ﹤0.01% |
+62,200
| New | +$3.12M |
|
2090
NLI Holdings
NL
$289M
| $3.12M | ﹤0.01% |
218,600
-84,200
| -28% | -$1.07M |
|
2091
Champion Homes
SKY
$4.41B
| $3.11M | ﹤0.01% |
242,200
+19,600
| +9% | +$241K |
|
|
RSYS
2092
DELISTED
Radisys Corp
RSYS
| $3.11M | ﹤0.01% |
3,094,099
+573,400
| +23% | +$612K |
|
2093
Ares Management
ARES
$28.1B
| $3.11M | ﹤0.01% |
155,279
+29,279
| +23% | +$549K |
|
2094
Larimar Therapeutics
LRMR
$377M
| $3.1M | ﹤0.01% |
55,914
-2,644
| -5% | -$119K |
|
2095
Mannatech
MTEX
$9.3M
| $3.1M | ﹤0.01% |
206,581
+6,221
| +3% | +$89.5K |
|
2096
StoneX
SNEX
$8.72B
| $3.09M | ﹤0.01% |
368,029
-153,900
| -29% | -$1.27M |
|
|
ALBO
2097
DELISTED
Albireo Pharma Inc
ALBO
| $3.09M | ﹤0.01% |
120,732
-14,800
| -11% | -$375K |
|
2098
Emcor
EME
$29.9B
| $3.09M | ﹤0.01% |
37,799
-144,901
| -79% | -$11.2M |
|
|
SCX
2099
DELISTED
The L.S. Starrett Company
SCX
| $3.09M | ﹤0.01% |
359,320
+14,020
| +4% | +$118K |
|
|
UWN
2100
DELISTED
Nevada Gold & Casinos, Ltd.
UWN
| $3.09M | ﹤0.01% |
1,156,700
+60,000
| +5% | +$143K |
|
Similar funds
Renaissance Technologies's Q4 2017 Portfolio in Review
As of Q4 2017, Renaissance Technologies held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Renaissance Technologies's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Renaissance Technologies added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Renaissance Technologies's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Renaissance Technologies fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Renaissance Technologies's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Renaissance Technologies opened 521 new positions and closed 386 in Q4 2017.
- Renaissance Technologies's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.